Elucidation of the Neutralizing Antibody Evasion of Emergent SARS-CoV-2 Omicron Sub-lineages Using Structural Analysis

Overview

Journal Sci China Life Sci

Specialties Biology
Science

Date 2023 Sep 6

PMID 37673846

Authors

Cong Sun

Yuan-Tao Liu

Yin-Feng Kang

Chu Xie

Shu-Xin Li

Yu-Tong Lu

Mu-Sheng Zeng

Affiliations

Soon will be listed here.

References

Arora P, Kempf A, Nehlmeier I, Schulz S, Jack H, Pohlmann S . Omicron sublineage BQ.1.1 resistance to monoclonal antibodies. Lancet Infect Dis. 2022; 23(1):22-23. PMC: 9707647. DOI: 10.1016/S1473-3099(22)00733-2. View

Barlow K, Conchuir S, Thompson S, Suresh P, Lucas J, Heinonen M . Flex ddG: Rosetta Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation. J Phys Chem B. 2018; 122(21):5389-5399. PMC: 5980710. DOI: 10.1021/acs.jpcb.7b11367. View

Cao Y, Jian F, Yu Y, Song W, Yisimayi A, Wang J . Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature. 2022; 614(7948):521-529. PMC: 9931576. DOI: 10.1038/s41586-022-05644-7. View

Gruell H, Vanshylla K, Weber T, Barnes C, Kreer C, Klein F . Antibody-mediated neutralization of SARS-CoV-2. Immunity. 2022; 55(6):925-944. PMC: 9118976. DOI: 10.1016/j.immuni.2022.05.005. View

Hoffmann M, Kruger N, Schulz S, Cossmann A, Rocha C, Kempf A . The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell. 2022; 185(3):447-456.e11. PMC: 8702401. DOI: 10.1016/j.cell.2021.12.032. View

Iketani S, Liu L, Guo Y, Liu L, Chan J, Huang Y . Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022; 604(7906):553-556. PMC: 9021018. DOI: 10.1038/s41586-022-04594-4. View

Kimura I, Yamasoba D, Tamura T, Nao N, Suzuki T, Oda Y . Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell. 2022; 185(21):3992-4007.e16. PMC: 9472642. DOI: 10.1016/j.cell.2022.09.018. View

Park Y, Pinto D, Walls A, Liu Z, De Marco A, Benigni F . Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. Science. 2022; 378(6620):619-627. DOI: 10.1126/science.adc9127. View

Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J . Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022; 602(7898):671-675. DOI: 10.1038/s41586-021-04389-z. View

10.

Que H, Chen L, Wei X . SARS-CoV-2 variants, immune escape, COVID-19 vaccine, and therapeutic strategies. Sci China Life Sci. 2022; 66(2):406-410. PMC: 9638196. DOI: 10.1007/s11427-021-2164-6. View

11.

Tzou P, Tao K, Kosakovsky Pond S, Shafer R . Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons. PLoS One. 2022; 17(3):e0261045. PMC: 8906623. DOI: 10.1371/journal.pone.0261045. View

12.

Wang Q, Iketani S, Li Z, Liu L, Guo Y, Huang Y . Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2022; 186(2):279-286.e8. PMC: 9747694. DOI: 10.1016/j.cell.2022.12.018. View

13.

Xie X, Cheng X, Wang G, Zhang B, Liu M, Chen L . Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19. Sci China Life Sci. 2021; 64(10):1634-1644. PMC: 7872720. DOI: 10.1007/s11427-020-1880-y. View